Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluvalAB Influenza Vaccine Serologic Clinical Trial 2006–2007
2006-002789-20Phase 4Completed
- Sponsor
- Omninvest
- Start
- May 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Fluval AB Novo in influenza, sponsored by Omninvest. Primary endpoints: Seroconversion ratio and Increase in geometric mean titer. Started May 2006; status: completed.
02
Drugs
Fluval AB Novo
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-002789-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002789-20.